이뮤노반트, Inc.
US ˙ NasdaqGS ˙ US45258J1025

SecurityIMVT / Immunovant, Inc.
InstitutionQUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series
Latest Disclosed Ownership118,374 shares
Latest Disclosed Value $ 1,893,984
QUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series reports 20.95% increase in ownership of IMVT / Immunovant, Inc.

On August 26, 2025 - QUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series filed a NPORT-P form disclosing ownership of 118,374 shares of Immunovant, Inc. (US:IMVT) valued at $1,893,984 USD as of June 30, 2025. The entity filed a previous NPORT-P on May 28, 2025 disclosing 97,871 shares of Immunovant, Inc.. This represents a change in shares of 20.95% during the quarter. The current value of the position is $3,682,615 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-08-26 2025-06-30 NP Immunovant EC US45258J1025 118,374 20,503 20.95 1,894 13.22 0.0425
2025-05-28 2025-03-31 NP Immunovant EC US45258J1025 97,871 0 0.00 1,673 -31.02 0.0401
2025-02-25 2024-12-31 NP Immunovant EC US45258J1025 97,871 -17,098 -14.87 2,424 -26.03 0.0529
2024-11-26 2024-09-30 NP Immunovant EC US45258J1025 114,969 12,665 12.38 3,278 21.37 0.0620
2024-08-26 2024-06-30 NP Immunovant EC US45258J1025 102,304 7,080 7.44 2,701 -12.22 0.0550
2024-05-28 2024-03-31 NP Immunovant EC US45258J1025 95,224 -3,021 -3.07 3,077 -25.68 0.0642
2024-02-26 2023-12-31 NP Immunovant EC US45258J1025 98,245 6,750 7.38 4,139 17.85 0.0883
2023-11-28 2023-09-30 NP Immunovant EC US45258J1025 91,495 -1,842 -1.97 3,512 98.42 0.0916
2023-08-25 2023-06-30 NP Immunovant EC US45258J1025 93,337 21,680 30.26 1,771 59.32 0.0420
2023-05-26 2023-03-31 NP Immunovant EC US45258J1025 71,657 2,154 3.10 1,111 -9.89 0.0296
2023-02-24 2022-12-31 NP Immunovant EC US45258J1025 69,503 5,066 7.86 1,234 243.45 0.0339
2022-11-25 2022-09-30 NP Immunovant EC US45258J1025 64,437 0 0.00 360 43.03 0.0103
2022-08-25 2022-06-30 NP Immunovant EC US45258J1025 64,437 0 0.00 251 -29.30 0.0069
2022-05-26 2022-03-31 NP Immunovant EC US45258J1025 64,437 6,002 10.27 355 -28.57 0.0083
2022-02-25 2021-12-31 NP Immunovant EC US45258J1025 58,435 0 0.00 498 -1.97 0.0108
2021-11-24 2021-09-30 NP Immunovant EC US45258J1025 58,435 0 0.00 508 -17.83 0.0112
2021-08-26 2021-06-30 NP Immunovant EC US45258J1025 58,435 0 0.00 618 -34.15 0.0132
2021-05-27 2021-03-31 NP Immunovant EC US45258J1025 58,435 0 0.00 937 -65.28 0.0213
2021-02-25 2020-12-31 NP Immunovant EC US45258J1025 58,435 1,396 2.45 2,699 34.48 0.0692
2020-11-25 2020-09-30 NP Immunovant EC US45258J1025 57,039 24,812 76.99 2,007 155.99 0.0644
2020-08-27 2020-06-30 NP Immunovant EC US45258J1025 32,227 32,227 785 0.0257
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.